demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19
COVID 19 hospitalizedCOVID 19 all comersCOVID-19 severe or critically
anti-interleukin-6
sarilumab CORIMUNO-SARI-1 ... sarilumab Sanofi phase 3 outside US
sarilumab high dose (400mg) Lescure ...
sarilumab low dose (200mg) Lescure ...
tocilizumab NCT04412772 ... RCT-TCZ-COVID-19 RECOVERY Declercq J ... NCT04577534 ... Soin AS ... EU-CTR2020-001375-32 ... EMPACTA EU-CTR2020-001748-24 ... NCT04479358 ... Dongsheng Wang Rutgers NCT04434717 ... BACC Bay Tocilizumab Trial Rosas ... COVACTA ... CORIMUNO-TOCI-1 ... MARIPOSA REMAP-CAP ... Talaschian Veiga CORIMUNO-TOCI-ICU ...